Frontier Biotechnologies Inc. (SHA:688221)
China · Delayed Price · Currency is CNY 14.06
+0.45 (3.31%)
At close: Oct 23, 2026
Frontier Biotechnologies Market Cap
Frontier Biotechnologies has a market cap or net worth of 5.27 billion as of October 23, 2026. It is the 11,600th most valuable company in the world and the 2,773rd biggest in China. Its market cap has decreased by 2.83% in one year.
Market Cap
5.27B
Enterprise Value
4.78B
Revenue
378.04M
Global Rank
Country Rank
#2,773 China
PE Ratio
n/a
ChartMarket Cap Chart
Since October 28, 2020, Frontier Biotechnologies's market cap has decreased from 10.76B to 5.27B, a decrease of -51.06%. That is a compound annual growth rate of -11.25%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 5.27B | -22.11% |
| Dec 31, 2025 | 6.76B | 84.94% |
| Dec 31, 2024 | 3.66B | -1.61% |
| Dec 29, 2023 | 3.72B | -42.53% |
| Dec 30, 2022 | 6.47B | -3.33% |
| Dec 31, 2021 | 6.69B | -3.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 28, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Hainan Haiyao | 5.53B |
| ZhuZhou QianJin Pharmaceutical Co.,Ltd | 5.44B |
| Beijing SL Pharmaceutical | 5.42B |
| Guizhou Xinbang Pharmaceutical | 5.40B |
| Jiangsu Jibeier Pharmaceutical | 5.34B |
| Bide Pharmatech | 5.29B |
| Hunan Jiudian Pharmaceutical | 5.26B |
| HPGC Renmintongtai Pharmaceutical | 5.24B |